Time to second biochemical recurrence as a prognostic indicator in postprostatectomy patients who undergo salvage radiation therapy: An RTOG 9601 based post hoc analysis

The prognostic significance of a “second” biochemical recurrence (sBCR) after salvage radiation therapy (sRT) with/without hormonal therapy following primary radical prostatectomy in men with prostate cancer has not been examined. We hypothesized that a shorter time to sBCR will be associated with worse cancer control outcomes.

[1]  A. Jemal,et al.  Cancer Statistics, 2021 , 2021, CA: a cancer journal for clinicians.

[2]  H. Weir,et al.  Prostate Cancer Incidence and Survival, by Stage and Race/Ethnicity — United States, 2001–2017 , 2020, MMWR. Morbidity and mortality weekly report.

[3]  R. Fisher,et al.  Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03/ANZUP RAVES): a randomised, controlled, phase 3, non-inferiority trial. , 2020, The Lancet Oncology.

[4]  L. Sumoy,et al.  PSA Kinetics as Prognostic Markers of Overall Survival in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Abiraterone Acetate , 2020, Cancer management and research.

[5]  H. G. van der Poel,et al.  Prognostic Value of Biochemical Recurrence Following Treatment with Curative Intent for Prostate Cancer: A Systematic Review. , 2019, European urology.

[6]  C. Roehrborn,et al.  Natural history of ‘second’ biochemical failure after salvage radiation therapy for prostate cancer: a multi‐institution study , 2018, BJU international.

[7]  J. Aragon-Ching,et al.  Role of chemotherapy in prostate cancer , 2017, Asian journal of andrology.

[8]  D. Grignon,et al.  Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer , 2017, The New England journal of medicine.

[9]  D. Mazhar,et al.  The evolving role of chemotherapy in prostate cancer. , 2017, Future oncology.

[10]  L. Salomon,et al.  Conditional Disease-free Survival After Radical Prostatectomy: Recurrence Risk Evolution Over Time. , 2016, Urology.

[11]  W. Jackson,et al.  The interval to biochemical failure is prognostic for metastasis, prostate cancer-specific mortality, and overall mortality after salvage radiation therapy for prostate cancer. , 2013, International journal of radiation oncology, biology, physics.

[12]  D. Curran‐Everett,et al.  Post-hoc data analysis: benefits and limitations. , 2013, Current opinion in allergy and clinical immunology.

[13]  Anthony V D'Amico,et al.  Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomes. , 2007, The Journal of urology.

[14]  Alan W Partin,et al.  Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy. , 2005, JAMA.

[15]  F. Thuillier,et al.  [PSA kinetics after radiotherapy]. , 2009, Annales de Biologie Clinique.